John K. Hsu has deep experience in intellectual property litigation and regularly litigates patent infringement and trade secret cases. Since 2006 his practice has focused on pharmaceutical litigation, representing generic drug manufacturers in high-stakes patent litigation brought under the Hatch-Waxman Act. With a Ph.D. in chemistry, John’s depth of scientific knowledge makes him uniquely qualified to advise his pharmaceutical clients and develop trial strategies for effective trial presentations or negotiating favorable settlements.
John has also worked extensively on appellate matters, including working on several U.S. Supreme Court and Federal Circuit appeals involving patent litigation.
- Successfully represented Fresenius Kabi USA, LLC in obtaining a rare preliminary injunction in federal district court. The injunction barred our client’s competitor from launching a generic version of its patented formulation of levothyroxine, an injectable thyroid hormone. The District Court for the District of New Jersey granted the injunction on the basis that our client was likely to win its patent lawsuit against its competitor.
- John has represented clients in all phases of litigation (including both jury and bench trials) before the federal district courts, the Court of Appeals for the Federal Circuit, the Supreme Court of the United States, and the United States International Trade Commission. He has also co-authored briefs submitted to the Supreme Court in noteworthy patent cases, including The Holmes Group, Inc. v. Vornado Air Circulation Systems, KSR Int’l Co. v. Teleflex, Inc., and EBay, Inc. v. MercExchange.
- University of Maryland Francis King Carey School of Law, J.D., 2000
- University of Maryland, Ph.D., Inorganic Chemistry, 1997
- Johns Hopkins University, B.A., Biology, 1990
- District of Columbia
- U.S. Patent and Trademark Office
Rate : $$$